- Home
- CVV vs SONN Comparison
CVV vs SONN Comparison
Compare CVV & SONN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CVV
- SONN
- Stock Information
- Founded
- CVV 1982
- SONN N/A
- Country
- CVV United States
- SONN United States
- Employees
- CVV N/A
- SONN N/A
- Industry
- CVV Industrial Machinery/Components
- SONN Biotechnology: Pharmaceutical Preparations
- Sector
- CVV Technology
- SONN Health Care
- Exchange
- CVV Nasdaq
- SONN Nasdaq
- Market Cap
- CVV 20.0M
- SONN 21.4M
- IPO Year
- CVV N/A
- SONN N/A
- Fundamental
- Price
- CVV $3.09
- SONN $7.26
- Analyst Decision
- CVV
- SONN Strong Buy
- Analyst Count
- CVV 0
- SONN 1
- Target Price
- CVV N/A
- SONN $20.00
- AVG Volume (30 Days)
- CVV 25.6K
- SONN 1.3M
- Earning Date
- CVV 11-12-2025
- SONN 08-13-2025
- Dividend Yield
- CVV N/A
- SONN N/A
- EPS Growth
- CVV N/A
- SONN N/A
- EPS
- CVV N/A
- SONN N/A
- Revenue
- CVV $29,036,000.00
- SONN $1,000,000.00
- Revenue This Year
- CVV N/A
- SONN $5,376.22
- Revenue Next Year
- CVV N/A
- SONN N/A
- P/E Ratio
- CVV N/A
- SONN N/A
- Revenue Growth
- CVV 34.35
- SONN 1689.52
- 52 Week Low
- CVV $2.46
- SONN $1.08
- 52 Week High
- CVV $4.80
- SONN $19.30
- Technical
- Relative Strength Index (RSI)
- CVV 52.55
- SONN 77.47
- Support Level
- CVV $2.95
- SONN $2.71
- Resistance Level
- CVV $3.17
- SONN $7.90
- Average True Range (ATR)
- CVV 0.19
- SONN 0.90
- MACD
- CVV 0.04
- SONN 0.46
- Stochastic Oscillator
- CVV 68.75
- SONN 87.67
About CVV CVD Equipment Corporation
CVD Equipment Corp is engaged in the manufacturing of chemical vapor deposition equipment, customized gas control systems, the manufacturing of process equipment suitable for the synthesis of a variety of one-dimensional nanostructures and nanomaterials and a line of furnaces, all of which are used to produce semiconductors and other electronic components. The company operates through the segments of CVD Equipment, CVD materials, and Stainless Design Concepts, MesoScribe. It generates maximum revenue from the CVD Equipment segment. The CVD Equipment segment manufactures and sells chemical vapor deposition, physical vapor transport, and similar equipment. Company operates in USA, North America, Europe, Middle East and Africa, and Asia-Pacific.
About SONN Sonnet BioTherapeutics Holdings Inc.
Sonnet BioTherapeutics Holdings Inc is a clinical-stage biotechnology company. The Company views its operations and manages its business in one segment. The company has developed FHAB (Fully Human Albumin Binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory, and hematological conditions. The firm's pipeline products include SON-080 (low-dose IL-6), SON-1210 (IL15- FHAB-IL12), SON-1010 (IL12-FHAB), and others.